Enzo Biochem, Inc. (NYSE:ENZ), a life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology.

Click Here To view Video http://www.crwenewswire.com/?p=83324

The company previously reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.

ENZ total revenues for the first quarter of fiscal 2011 increased to $25.7 million, from $25.2 million a year ago, or 2%, despite slightly lower revenues at Life Sciences resulting from a program to emphasize higher margined products, and advanced 3% sequentially. Enzo Clinical Labs benefited from an increase in market share and a new provider contract.

The company gross profit margin improved 17% to $13.5 million, or 53% of revenues, compared to the fiscal 2010 fourth quarter’s $11.5 million and was a slight improvement year over year.

The business activities of Enzo Biochem are performed by the company’s three wholly owned subsidiaries . . . Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical Labs. Such activities include research and development, manufacturing and marketing of biomedical research products and tools through Enzo Life Sciences and research and development of therapeutic products through Enzo Therapeutics and the operation of a regional clinical reference laboratory through Enzo Clinical Labs.

Enzo’s vision of the importance of recombinant DNA technology as an informational source more than two decades ago has now become a major direction in modern medicine.

For more information about this company please visit http://www.enzo.com

****

DCT Industrial Trust, Inc. (NYSE:DCT) reported the acquisition of nine properties in Southern California with a total value of $79.5 million. The buildings are being acquired in three transactions, including one for the controlling interests in five distribution facilities, a second for three cross-dock truck terminals and a third for a single bulk distribution building. The $79.5 million purchase price reflects an average $57.50 per square foot value for the distribution buildings and approximately $126,900 per door value for the truck terminals.

DCT Industrial Trust Inc. operates as a publicly owned real estate investment trust. The firm provides its services to companies. Through its fund, it engages in the ownership, operation, and development of real estate properties.

****

Gramercy Capital Corp. (NYSE:GKK) previously announced the closing of the sale of certain real estate investments to SL Green Realty Corp. (NYSE:SLG) for an aggregate price of approximately $390.8 million, including the assumption by SL Green of approximately $265.6 million in debt. The transactions closed on substantially the same terms as previously disclosed and produced approximately $89.8 million of unrestricted cash for the Company and approximately $39.0 million of restricted cash for one of the Company’s three CDOs.

Gramercy Capital Corp. is a real estate investment trust specializing in the origination and acquisition of first mortgage loans; subordinate interests in whole loans (B Notes); mezzanine financing; preferred equity; bridge loans; and permanent loans.

****

Newpark Resources, Inc. (NYSE:NR) will release its fourth quarter and year-end 2010 results on Thursday, February 17, 2011 after the market closes. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the Internet, for Friday, February 18, 2011 at 10:00 a.m. Eastern / 9:00 a.m. Central. Newpark Resources Fourth Quarter 2010 Earnings Conference Call Friday, February 18, 2011 at 10:00 a.m. Eastern / 9:00 a.m. Central Live via phone By dialing 480-629-9771 and asking for the Newpark Resources call at least 10 minutes prior to the start time, or Live over the Internet -- By logging onto the web at http://www.newpark.com.

Newpark Resources, Inc. and its subsidiaries provide fluids management, waste disposal, and well site preparation products and services primarily to the oil and gas exploration and production industry.

CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.

Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

ENZcrweselect0112